Hence, to determine whether the early T cell response induced by Ubr5 deletion was responsible for the observed tumor diminution, we compared tumor growth in Rag2−/− mice, CD4-deficient mice and CD8-deficient mice. Here, UBR5 is linked to neoplasm.